Home

The price of false prophecy

1998-11-19T00:00:00

'Many cancer trials in recent decades have measured the end joint (the outcome) in terms of additional months or years of life. Trialists have been very reluctant to measure the quality of the additional time.'

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here